Literature DB >> 24969950

[High-functioning autism spectrum disorders in adulthood].

K Koelkebeck1, A Riedel, P Ohrmann, M Biscaldi, L Tebartz van Elst.   

Abstract

The prevalence of autism spectrum disorders in the general population is approximately 1 %. Some individuals with high-functioning autism graduate from regular schools without autism having been diagnosed and problems only occur when the demands for social competence increase. Then patients often present with secondary psychiatric symptoms, such as depression, anxiety or interpersonal problems. At this time, typical autistic features, such as social interaction deficits, restricted interests and stereotypic behavior can be camouflaged by high compensatory skills, particularly in highly intelligent patients. Therefore, missed or wrong diagnoses are frequent. Interviews, questionnaires and neuropsychological tests might be used to support the diagnosis. In cases where there is evidence for a secondary cause of autistic symptoms, somatic disorders should be excluded. Pharmacological treatment should be symptom-oriented. Individualized psychotherapeutic approaches are becoming increasingly more available; however, pragmatic solutions often need to be deployed.

Entities:  

Mesh:

Year:  2014        PMID: 24969950     DOI: 10.1007/s00115-014-4050-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  Asperger syndrome and autism: a comparative longitudinal follow-up study more than 5 years after original diagnosis.

Authors:  Mats Cederlund; Bibbi Hagberg; Eva Billstedt; I Carina Gillberg; Christopher Gillberg
Journal:  J Autism Dev Disord       Date:  2007-03-06

2.  Autism: cognitive deficit or cognitive style?

Authors: 
Journal:  Trends Cogn Sci       Date:  1999-06       Impact factor: 20.229

3.  [Psychosocial functioning of adults with late diagnosed autism spectrum disorders--a retrospective study].

Authors:  F-G Lehnhardt; A Gawronski; K Volpert; L Schilbach; R Tepest; K Vogeley
Journal:  Fortschr Neurol Psychiatr       Date:  2011-11-15       Impact factor: 0.752

Review 4.  Autism in adults. New biologicial findings and their translational implications to the cost of clinical services.

Authors:  Declan G M Murphy; Jennifer Beecham; Michael Craig; Christine Ecker
Journal:  Brain Res       Date:  2010-10-20       Impact factor: 3.252

5.  Brain mechanisms for social perception: lessons from autism and typical development.

Authors:  Kevin A Pelphrey; Elizabeth J Carter
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  Deconstructing executive deficits among persons with autism: implications for cognitive neuroscience.

Authors:  Natalie Russo; Tara Flanagan; Grace Iarocci; Darlene Berringer; Philip David Zelazo; Jacob A Burack
Journal:  Brain Cogn       Date:  2007-09-07       Impact factor: 2.310

7.  Oxytocin enhances brain function in children with autism.

Authors:  Ilanit Gordon; Brent C Vander Wyk; Randi H Bennett; Cara Cordeaux; Molly V Lucas; Jeffrey A Eilbott; Orna Zagoory-Sharon; James F Leckman; Ruth Feldman; Kevin A Pelphrey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  A meta-analysis of differences in IQ profiles between individuals with Asperger's disorder and high-functioning autism.

Authors:  Hsu-Min Chiang; Luke Y Tsai; Ying Kuen Cheung; Alice Brown; Huacheng Li
Journal:  J Autism Dev Disord       Date:  2014-07

9.  Early adolescent outcomes of institutionally deprived and non-deprived adoptees. III. Quasi-autism.

Authors:  Michael Rutter; Jana Kreppner; Carla Croft; Marianna Murin; Emma Colvert; Celia Beckett; Jenny Castle; Edmund Sonuga-Barke
Journal:  J Child Psychol Psychiatry       Date:  2007-12       Impact factor: 8.982

Review 10.  What's in the pipeline? Drugs in development for autism spectrum disorder.

Authors:  Min Sung; Chee Hon Chin; Choon Guan Lim; Hwee Sen Alvin Liew; Chau Sian Lim; Espérance Kashala; Shih-Jen Weng
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.